Champions Oncology Stock Price History
| CSBR Stock | USD 4.31 0.02 0.46% |
Below is the normalized historical share price chart for Champions Oncology extending back to November 29, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Champions Oncology stands at 4.31, as last reported on the 29th of November, with the highest price reaching 4.32 and the lowest price hitting 4.18 during the day.
If you're considering investing in Champions Stock, it is important to understand the factors that can impact its price. Currently, Champions Oncology is relatively risky. Champions Oncology secures Sharpe Ratio (or Efficiency) of 0.0342, which signifies that the company had a 0.0342% return per unit of standard deviation over the last 3 months. We have found twenty-three technical indicators for Champions Oncology, which you can use to evaluate the volatility of the firm. Please confirm Champions Oncology's risk adjusted performance of 5.0E-4, and Mean Deviation of 3.36 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%.
At this time, Champions Oncology's Common Stock Total Equity is relatively stable compared to the past year. As of 11/29/2024, Common Stock Shares Outstanding is likely to grow to about 14.2 M, while Treasury Stock is likely to drop (1.2 M). . As of 11/29/2024, Price To Sales Ratio is likely to drop to 1.24. In addition to that, Price Earnings Ratio is likely to grow to -8.58. Champions Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of January 2003 | 200 Day MA 4.8113 | 50 Day MA 4.443 | Beta 0.493 |
Champions |
Sharpe Ratio = 0.0342
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CSBR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.47 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Champions Oncology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Champions Oncology by adding it to a well-diversified portfolio.
Price Book 6.7705 | Enterprise Value Ebitda 26.2588 | Price Sales 1.1342 | Shares Float 4.8 M | Wall Street Target Price 6 |
Champions Oncology Stock Price History Chart
There are several ways to analyze Champions Stock price data. The simplest method is using a basic Champions candlestick price chart, which shows Champions Oncology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 13, 2024 | 5.05 |
| Lowest Price | October 30, 2024 | 3.79 |
Champions Oncology November 29, 2024 Stock Price Synopsis
Various analyses of Champions Oncology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Champions Stock. It can be used to describe the percentage change in the price of Champions Oncology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Champions Stock.| Champions Oncology Price Daily Balance Of Power | (0.14) | |
| Champions Oncology Price Rate Of Daily Change | 1.00 | |
| Champions Oncology Price Action Indicator | 0.05 |
Champions Oncology November 29, 2024 Stock Price Analysis
Champions Stock Price History Data
The price series of Champions Oncology for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 1.26 with a coefficient of variation of 6.32. The prices are distributed with arithmetic mean of 4.43. The median price for the last 90 days is 4.47. The company had 1:12 stock split on 12th of August 2015.| Open | High | Low | Close | Volume | ||
11/29/2024 | 4.19 | 4.32 | 4.18 | 4.31 | ||
| 11/27/2024 | 4.19 | 4.32 | 4.18 | 4.31 | 1,213 | |
| 11/26/2024 | 4.11 | 4.35 | 4.08 | 4.33 | 13,140 | |
| 11/25/2024 | 4.26 | 4.42 | 4.17 | 4.18 | 16,932 | |
| 11/22/2024 | 4.37 | 4.65 | 4.30 | 4.55 | 9,200 | |
| 11/21/2024 | 4.39 | 4.67 | 4.27 | 4.27 | 5,806 | |
| 11/20/2024 | 4.42 | 4.64 | 4.26 | 4.32 | 22,552 | |
| 11/19/2024 | 4.60 | 4.70 | 4.51 | 4.55 | 10,039 | |
| 11/18/2024 | 4.38 | 4.58 | 4.34 | 4.52 | 3,758 | |
| 11/15/2024 | 4.46 | 4.65 | 4.35 | 4.50 | 4,949 | |
| 11/14/2024 | 4.49 | 4.67 | 4.46 | 4.46 | 2,586 | |
| 11/13/2024 | 4.59 | 4.70 | 4.51 | 4.60 | 32,463 | |
| 11/12/2024 | 4.49 | 4.64 | 4.43 | 4.64 | 5,922 | |
| 11/11/2024 | 4.44 | 4.60 | 4.30 | 4.51 | 4,337 | |
| 11/08/2024 | 4.47 | 4.59 | 4.43 | 4.47 | 2,369 | |
| 11/07/2024 | 4.31 | 4.32 | 4.26 | 4.32 | 1,514 | |
| 11/06/2024 | 4.17 | 4.58 | 4.12 | 4.26 | 17,352 | |
| 11/05/2024 | 4.08 | 4.47 | 4.07 | 4.09 | 7,197 | |
| 11/04/2024 | 3.97 | 4.24 | 3.96 | 4.24 | 6,614 | |
| 11/01/2024 | 3.84 | 4.02 | 3.79 | 4.00 | 21,401 | |
| 10/31/2024 | 3.89 | 3.97 | 3.75 | 3.91 | 22,905 | |
| 10/30/2024 | 3.83 | 3.93 | 3.79 | 3.79 | 12,503 | |
| 10/29/2024 | 3.85 | 3.99 | 3.85 | 3.97 | 12,039 | |
| 10/28/2024 | 4.02 | 4.03 | 3.82 | 3.98 | 14,175 | |
| 10/25/2024 | 4.17 | 4.21 | 3.96 | 4.08 | 18,625 | |
| 10/24/2024 | 4.00 | 4.36 | 4.00 | 4.26 | 5,159 | |
| 10/23/2024 | 4.39 | 4.44 | 4.00 | 4.01 | 28,784 | |
| 10/22/2024 | 4.45 | 4.52 | 4.35 | 4.37 | 9,479 | |
| 10/21/2024 | 4.30 | 4.50 | 4.30 | 4.50 | 2,943 | |
| 10/18/2024 | 4.43 | 4.45 | 4.37 | 4.42 | 2,055 | |
| 10/17/2024 | 4.53 | 4.58 | 4.42 | 4.44 | 4,224 | |
| 10/16/2024 | 4.35 | 4.74 | 4.30 | 4.56 | 44,063 | |
| 10/15/2024 | 4.37 | 4.57 | 4.30 | 4.54 | 8,872 | |
| 10/14/2024 | 4.54 | 4.63 | 4.36 | 4.37 | 7,861 | |
| 10/11/2024 | 4.65 | 4.80 | 4.54 | 4.54 | 4,184 | |
| 10/10/2024 | 4.68 | 4.80 | 4.50 | 4.69 | 7,757 | |
| 10/09/2024 | 4.67 | 4.79 | 4.52 | 4.66 | 8,957 | |
| 10/08/2024 | 4.79 | 4.79 | 4.59 | 4.59 | 3,471 | |
| 10/07/2024 | 4.70 | 4.84 | 4.66 | 4.67 | 5,653 | |
| 10/04/2024 | 4.50 | 4.79 | 4.50 | 4.79 | 3,256 | |
| 10/03/2024 | 4.52 | 4.78 | 4.51 | 4.54 | 16,385 | |
| 10/02/2024 | 4.58 | 4.89 | 4.51 | 4.51 | 10,627 | |
| 10/01/2024 | 4.79 | 4.79 | 4.53 | 4.64 | 5,131 | |
| 09/30/2024 | 4.78 | 4.91 | 4.48 | 4.87 | 19,940 | |
| 09/27/2024 | 4.89 | 5.10 | 4.69 | 4.72 | 41,607 | |
| 09/26/2024 | 4.86 | 5.04 | 4.75 | 4.81 | 53,815 | |
| 09/25/2024 | 4.70 | 4.86 | 4.65 | 4.85 | 13,257 | |
| 09/24/2024 | 4.51 | 4.76 | 4.43 | 4.71 | 17,012 | |
| 09/23/2024 | 4.77 | 4.77 | 4.28 | 4.58 | 29,061 | |
| 09/20/2024 | 4.81 | 4.97 | 4.71 | 4.77 | 33,091 | |
| 09/19/2024 | 4.41 | 4.89 | 4.41 | 4.89 | 76,253 | |
| 09/18/2024 | 4.64 | 4.80 | 4.28 | 4.28 | 40,236 | |
| 09/17/2024 | 5.06 | 5.12 | 4.60 | 4.60 | 61,345 | |
| 09/16/2024 | 5.13 | 5.45 | 5.00 | 5.00 | 116,302 | |
| 09/13/2024 | 4.71 | 5.11 | 4.40 | 5.05 | 194,650 | |
| 09/12/2024 | 4.70 | 5.23 | 4.11 | 4.46 | 2,118,841 | |
| 09/11/2024 | 3.99 | 4.70 | 3.90 | 4.07 | 163,705 | |
| 09/10/2024 | 4.18 | 4.45 | 3.60 | 3.95 | 26,361 | |
| 09/09/2024 | 4.05 | 4.23 | 4.05 | 4.23 | 10,469 | |
| 09/06/2024 | 4.25 | 4.25 | 4.25 | 4.25 | 192.00 | |
| 09/05/2024 | 4.31 | 4.56 | 4.25 | 4.25 | 2,441 |
About Champions Oncology Stock history
Champions Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Champions is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Champions Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Champions Oncology stock prices may prove useful in developing a viable investing in Champions Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13.5 M | 14.2 M | |
| Net Loss | -6.1 M | -6.4 M |
Champions Oncology Stock Technical Analysis
Champions Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Champions Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Champions Oncology's price direction in advance. Along with the technical and fundamental analysis of Champions Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Champions to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 5.0E-4 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Champions Stock Analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.